REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
11/05/2026
Voltar para busca
Dado oficial do USPTO
AGOS
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
AGOS
ST13
US500000088718586Classe
9, 35, 38, 42, 44
Pedido
88718586
Registro
6344572
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
26
Atualização mais recente
12/05/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
9, 35, 38, 42, 44
Data de depósito
06/12/2019
Data de registro
11/05/2021
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
11/05/2021
Última transação
12/05/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Foreign priority
Código do desenho
4
Tipo de titular
99
Localização do titular
Hitchin, GB
Examinador
REID, CAILE MAUREEN
Unidade examinadora
N50
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
Agos Healthcare Limited
Representantes
Richard M. LaBarge MARSHALL, GERSTEIN & BORUN LLP
Classificação técnica
Classes Nice
Classe 9Classe 35Classe 38Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 9
Downloadable and recorded computer software for use as a database and for analysing data in the fields of pharmaceuticalsclinical trialsclinical research and biotechnology; Downloadable software applications for computerslaptops and mobile phones featuring software for use as a database and for collatingstoringanalysingutilizing data in the fields of pharmaceuticalsclinical trialsclinical research and biotechnology; Downloadable and recorded software for secure data storage and retrieval and transmission of customer and client information; Downloadable and recorded computer software for use as a database and for collatingstoringanalysing and utilizing data in the field of pharmaceuticalsclinical trialsclinical research and biotechnology; downloadable and recorded computer operating programs and downloadable and recorded application development software for use on or in connection with mobile phonestablets and handheld devices in the field of pharmaceuticalsclinical trialsclinical research and biotechnology; data processing equipment and computers; Downloadable electronic publications in the nature of e-booksmagazinesnewsletters and reports provided on-line from a database or the internet in the fields of pharmaceuticalsclinical trialsclinical research and biotechnology
Classe 35
Business project and risk management services in the field of pharmaceuticalsclinical trialsclinical research and biotechnology; business consultancy services; Business project and risk management and consultancy services in the field of clinical trials and clinical research; Business consulting and management in the field of clinical trialsclinical data and regulatory submission management services for medicalbiopharmaceutical and biotechnology companies to assist them with clinical researchclinical trials and applications for drug approval; providing business information management services on clinical trials and clinical research; providing business intelligence services in the fields of medical devicespharmaceuticals and the life sciences; providing business management information in connection with consultancy and advisory services in the field of strategic planning; regulatory submission managementbusiness strategic planningpreparing and submitting applications for others for new medical devicesnew pharmaceuticalsvariations on previously approved medical devicesvariations on previously approved pharmaceuticals to receive clinical trial approval or marketing authorization from governmental regulatory bodies; regulatory submission managementassisting others with strategic business planningpreparing and filing applications with governmental regulatory bodies for approval of new medical devices and new pharmaceuticals; Regulatory submission managementassisting others in preparing and filing applications for new drugs with governmental regulatory bodies; New pharmaceutical and biotechnology product commercialization services; consultancy services for others in the field of new pharmaceutical and biotechnology product commercialization; informationadvice and consultancy services in relation to all the aforesaid services
Classe 38
Providing Internet accessproviding access to platforms and portals on the internet in the field of pharmaceuticalsclinical trialsclinical research and biotechnology; providing user access to global computer networksproviding user access to platforms and portals on the internet in the field of pharmaceuticalsclinical trialsclinical research and biotechnology; informationadvice and consultancy services in relation to all the aforesaid services
Classe 42
Providing medical and scientific research information in the field of pharmaceuticalsclinical trialsclinical research and biotechnology; Product and scientific research and development in the field of pharmaceuticalsclinical trialsclinical researchmedical devices and biotechnology; Consultancy services for others in the field of technical consultancy for pharmaceuticalsdesignplanningimplementation consultancy for clinical trialsconsultancy on scientific clinical researchdesign and development consultancy for medical devices; conducting early evaluations in the field of new pharmaceuticals; consultancy services in the field of designplanningimplementation and project management of clinical trialspharmacovigilancepharmaceutical and biotechnology product development; consultancy services in the fields of biotechnologypharmaceutical research and developmentlaboratory testing and pharmacogenetics; medical and scientific research; conducting clinical trials for others; pharmaceutical drug development services; development of pharmaceutical preparations and medicines; pharmaceutical product evaluation; pharmaceutical research and development; product development consultancy in the field of pharmaceuticals and biotechnology; testing and quality control evaluation of products in the field of pharmaceuticalsclinical trials and biotechnology; product testing and quality control evaluation of pharmaceutical preparations and medicines; testing and quality control in the nature of conducting clinical trials in the field of pharmaceuticals and biotechnology for others; Software as a Service (SaaS) featuring software for use as a database and for analysing data in the fields of in the field of pharmaceuticalsclinical trialsclinical research and biotechnology; providing online non-downloadable software applications for use in creatingdesigninghostingpublishingmanaging and maintaining content for use on the internet for website and media content management purposes; application service provider featuring application programming interface (API) software to allow people to view data through an interactive mapto query datato generate reports and to access data and documents; software as a service (SAAS) featuring computer software to enable the displayingreceiving and transmitting of data to enable the purchase of goods and services; informationadvice and consultancy services in relation to all the aforesaid services
Classe 44
Managed healthcare services being medical services in the field of pharmaceuticalsclinical trialsclinical research and biotechnology; consultancy services in the field of medical information services; medical consultancy services in the field of pharmaceuticalsclinical trialsclinical research and biotechnology; consultancy services in the field of biotechnology diagnostics and pharmacogenetics diagnostics medical testing; medical informationadvice and consultancy services in the pharmaceutical and healthcare sectors; medical informationadvice and consultancy services in relation to pharmacovigilance; informationadvice and consultancy services in relation to all the aforesaid services
Publicações
Histórico de despachos e eventos da marca no USPTO.
26 publicações encontradas
R.PR
REGISTERED-PRINCIPAL REGISTER
11/05/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
23/02/2021
PUBO
PUBLISHED FOR OPPOSITION
23/02/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/02/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
21/01/2021
XAEC
EXAMINER'S AMENDMENT ENTERED
21/01/2021
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
21/01/2021
GNEA
EXAMINERS AMENDMENT E-MAILED
21/01/2021
CNEA
EXAMINERS AMENDMENT -WRITTEN
21/01/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
19/01/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
19/01/2021
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
19/01/2021
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
26/10/2020
GNFR
FINAL REFUSAL E-MAILED
26/10/2020
CNFR
FINAL REFUSAL WRITTEN
26/10/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
20/10/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
20/10/2020
ALIE
ASSIGNED TO LIE
19/10/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/09/2020
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
09/03/2020
GNRT
NON-FINAL ACTION E-MAILED
09/03/2020
CNRT
NON-FINAL ACTION WRITTEN
09/03/2020
DOCK
ASSIGNED TO EXAMINER
06/03/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/12/2019
NWAP
NEW APPLICATION ENTERED
10/12/2019
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace AGOS ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.